4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-012064
Chairman and CEO bought 19,300 shares at an average $1.44 ($27,777)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-02-18 | Purchase | +1,500 | $1.43 | $2,145 | 11,215,406 | D |
| Niihara Yutaka Chairman and CEO | 2022-02-22 | Purchase | +17,800 | $1.44 | $25,632 | 11,233,206 | D |
| Open-market purchases · 19,300 sh · avg $1.44 · $27,777 | |||||||
Loading xslF345X03/doc4.xml…